GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nano Mrna Co Ltd (TSE:4571) » Definitions » Debt-to-Revenue

Nano Mrna Co (TSE:4571) Debt-to-Revenue : 21.00 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Nano Mrna Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Nano Mrna Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円0.0 Mil. Nano Mrna Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円1,108.9 Mil. Nano Mrna Co's annualized Revenue for the quarter that ended in Dec. 2023 was 円52.8 Mil. Nano Mrna Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 21.00.


Nano Mrna Co Debt-to-Revenue Historical Data

The historical data trend for Nano Mrna Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nano Mrna Co Debt-to-Revenue Chart

Nano Mrna Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 4.36 5.49 8.18

Nano Mrna Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.61 4.71 8.61 21.00 8.89

Competitive Comparison of Nano Mrna Co's Debt-to-Revenue

For the Biotechnology subindustry, Nano Mrna Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nano Mrna Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nano Mrna Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nano Mrna Co's Debt-to-Revenue falls into.



Nano Mrna Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Nano Mrna Co's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 1108.916) / 135.508
=8.18

Nano Mrna Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 1108.916) / 52.8
=21.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Nano Mrna Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nano Mrna Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nano Mrna Co (TSE:4571) Business Description

Traded in Other Exchanges
Address
5-4-19 Kashiwanoha, Chiba, JPN, 277-0882
Nano Mrna Co Ltd formerly NanoCarrier Co Ltd is engaged in the research and development of pharmaceuticals using micellar nanoparticles technology.

Nano Mrna Co (TSE:4571) Headlines

No Headlines